Published in Hum Reprod on May 01, 1997
Serum progesterone concentration on day of embryo transfer in donor oocyte cycles. J Assist Reprod Genet (2014) 0.83
Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application. J Antimicrob Chemother (2013) 0.83
Vaginal drug delivery for the localised treatment of cervical cancer. Drug Deliv Transl Res (2017) 0.83
Pregnancy outcomes in oocyte donation recipients: vaginal gel versus intramuscular injection progesterone replacement. J Assist Reprod Genet (2012) 0.82
The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections--a pharmacokinetic study. Reprod Biol Endocrinol (2009) 0.75
Levonorgestrel-IUS system and endometrial manipulation. J Midlife Health (2013) 0.75
A multi-center, randomized, open-label, parallel group study of a natural micronized progesterone vaginal tablet as a luteal support agent in Japanese women undergoing assisted reproductive technology. Reprod Med Biol (2015) 0.75
Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial. Trials (2012) 0.75
Progesterone vaginal ring for luteal support. J Obstet Gynaecol India (2014) 0.75
Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod (2001) 2.24
Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod (1998) 1.80
Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst (1996) 1.77
Sperm DNA fragmentation: paternal effect on early post-implantation embryo development in ART. Hum Reprod (2006) 1.63
Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril (1997) 1.47
[Use of aromatase inhibitors in infertile women]. Gynecol Obstet Fertil (2005) 1.43
Gamete intrafallopian transfer by hysteroscopy as an alternative treatment for infertility. Fertil Steril (1991) 1.39
Gamete intrafallopian transfer: prospective randomized comparison between hysteroscopic and laparoscopic transfer techniques. Fertil Steril (1995) 1.39
Financial impact in the Italian Health Service of laparoscopic versus laparotomic surgery for the treatment of ovarian cysts. Hum Reprod (1996) 1.39
Prolactin in hypothalamic-hypophysial blood. Lancet (1989) 1.38
Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod (2000) 1.38
Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod (2005) 1.32
Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev (1995) 1.22
Pre-hCG elevation of plasma progesterone: good, bad or otherwise. Hum Reprod Update (2008) 1.22
Reproductive failure due to spontaneous abortion and recurrent miscarriage. Hum Reprod Update (1997) 1.16
Direct transport of progesterone from vagina to uterus. Obstet Gynecol (2000) 1.16
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev (1996) 1.14
Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril (1997) 1.11
Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod (1994) 1.10
Four indications for embryo transfer at the blastocyst stage. Hum Reprod (1994) 1.07
Clinical experience and applications of oocyte cryopreservation. Mol Cell Endocrinol (2000) 1.07
Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril (1993) 1.06
Uterine contractility during the menstrual cycle. Hum Reprod (2000) 1.06
Screening for activated protein C resistance before oral contraceptive treatment: a pilot study. Contraception (1999) 1.02
Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus. Hum Reprod Update (1999) 1.02
Adhesion formation after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc (1996) 1.01
Follicular fluid and human granulosa cell cultures: influence on sperm kinetic parameters, hyperactivation, and acrosome reaction. Fertil Steril (1998) 0.98
Perifollicular vascularity and its relationship with oocyte maturity and IVF outcome. Ann N Y Acad Sci (2001) 0.95
New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril (2000) 0.95
Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence. Pediatr Res (1995) 0.95
Oocyte donation program: pregnancy and implantation rates in women of different ages sharing oocytes from single donor. Fertil Steril (1996) 0.95
Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab (1993) 0.94
Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril (2001) 0.94
Permeability of human oocytes to ethylene glycol and their survival and spindle configurations after slow cooling cryopreservation. Hum Reprod (2007) 0.94
Study of aneuploidy in normal and abnormal germ cells from semen of fertile and infertile men. Hum Reprod (1998) 0.93
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab (1999) 0.92
Alcohol consumption and total estradiol in premenopausal women. Cancer Epidemiol Biomarkers Prev (1998) 0.91
Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J Am Coll Cardiol (2000) 0.91
Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist. Hum Reprod (1992) 0.91
Transfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP). Fertil Steril (1989) 0.91
Meiotic spindle imaging in human oocytes frozen with a slow freezing procedure involving high sucrose concentration. Hum Reprod (2005) 0.90
Determination of a dark-induced increase of pineal N-acetyl transferase activity and simultaneous radioimmunoassay of melatonin in pineal, serum and pituitary tissue of the male rat. J Endocrinol (1977) 0.90
Evolution of a highly successful in vitro fertilization-embryo transfer program. Fertil Steril (1987) 0.90
Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril (1987) 0.90
Frequency and treatment of ovarian cysts in adolescence. Arch Gynecol Obstet (1994) 0.89
The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc (1999) 0.89
Comparison between depot and standard release triptoreline in in vitro fertilization: pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results. Fertil Steril (1994) 0.89
Ultrastructure of human mature oocytes after slow cooling cryopreservation using different sucrose concentrations. Hum Reprod (2006) 0.89
Differential sucrose concentration during dehydration (0.2 mol/l) and rehydration (0.3 mol/l) increases the implantation rate of frozen human oocytes. Reprod Biomed Online (2007) 0.89
Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Hum Reprod (2001) 0.88
Hormonal influence on the uterine contractility during ovarian stimulation. Hum Reprod (2000) 0.88
The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril (1994) 0.88
Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstet Gynecol (1984) 0.88
Preoperative localization of androgen-secreting tumors: clinical, endocrinologic, and radiologic evaluation of ten patients. Am J Obstet Gynecol (1988) 0.87
Uterine development and endocrine relationships after menarche. Am J Obstet Gynecol (1989) 0.86
The successful use of human amniotic fluid for mouse embryo culture and human in vitro fertilization, embryo culture, and transfer. Fertil Steril (1986) 0.86
Isolation of prolactin-producing cells from first and second trimester decidua. J Clin Endocrinol Metab (1984) 0.86
Ultrastructure of human mature oocytes after slow cooling cryopreservation with ethylene glycol. Reprod Biomed Online (2008) 0.86
Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril (1996) 0.86
Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. Fertil Steril (1992) 0.86
Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reprod Biomed Online (2013) 0.86
Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation. Fertil Steril (1999) 0.86
Longitudinal evaluation of the different gonadotropin pulsatile patterns in anovulatory cycles of young girls. J Clin Endocrinol Metab (1992) 0.86
Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology. Horm Res (1986) 0.85
Circadian variations of luteinizing hormone can have two different profiles in adolescent anovulation. J Clin Endocrinol Metab (1987) 0.85
Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study. Hum Reprod (2004) 0.85
T-helper 2 type cytokine and soluble interleukin-2 receptor levels in seminal plasma of infertile men. Am J Reprod Immunol (1997) 0.84
Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil Steril (1996) 0.84
Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil Steril (1991) 0.84
Pregnancies in postmenopausal women over 50 years old in an oocyte donation program. Fertil Steril (1995) 0.83
Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. J Clin Endocrinol Metab (1991) 0.83
A histological and immunohistochemical study of neuropeptide containing somatic nerves in the levator ani muscle of women with genitourinary prolapse. Acta Obstet Gynecol Scand (1999) 0.83
Physiology and pathophysiology of pulsatile gonadotropin secretion. Gynecol Endocrinol (1988) 0.82
A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab (1996) 0.82
Immunologically mediated abortion (IMA). J Steroid Biochem Mol Biol (1994) 0.82
Criteria to assess human oocyte quality after cryopreservation. Reprod Biomed Online (2005) 0.81
Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase. Hum Reprod (1992) 0.81
Improvement of pregnancy and implantation rates in cyclic women undergoing oocyte donation after long-term down-regulation. Hum Reprod (1995) 0.81
Ovarian multifollicularity, high LH and androgen plasma levels, and anovulation are frequent and strongly linked in adolescent irregular cycles. Acta Endocrinol (Copenh) (1986) 0.81
Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril (1993) 0.81
Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization. Fertil Steril (1997) 0.81
Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Hum Reprod (1998) 0.81
[Neurotrophins and pain in endometriosis]. Gynecol Obstet Fertil (2010) 0.81
Endometriosis: absence of recurrence in patients after endometrial ablation. Hum Reprod (2001) 0.81
Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol. Arch Gynecol (1985) 0.81
Technical aspects of oocyte cryopreservation. Mol Cell Endocrinol (2000) 0.81
Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome. Clin Endocrinol (Oxf) (1988) 0.81
Volume changes of mature human oocytes on exposure to cryoprotectant solutions used in slow cooling procedures. Hum Reprod (2005) 0.81
Different gonadotropin pulsatile fashions in anovulatory cycles of young girls indicate different maturational pathways in adolescence. J Clin Endocrinol Metab (1987) 0.81
Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta Endocrinol (Copenh) (1991) 0.81
Controlled ovarian hyperstimulation in women > or = 40 years old undergoing IVF-ET: mid-luteal versus early follicular (flare-up) GnRH analog regimens. Acta Eur Fertil (1997) 0.81